Illumina Inc (NASDAQ:ILMN)

344.62
BATS BZX Real-Time Price
As of 12:40pm ET
 -13.12 / -3.67%
Today’s Change
335.68
Today|||52-Week Range
555.77
-6.86%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$57.8B

Company Description

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Contact Information

Illumina, Inc.
5200 Illumina Way
San Diego California 92122
P:(858) 202-4500
Investor Relations:
(858) 200-6583

Employees

Shareholders

Mutual fund holders50.79%
Individual stakeholders5.97%
Other institutional37.15%

Top Executives

Francis A. deSouzaPresident, Chief Executive Officer & Director
Robert P. RagusaChief Operations Officer
Sam A. SamadChief Financial Officer & Senior Vice President
Phillip G. FebboChief Medical Officer
Alex AravanisCTO, Head-Research & Product Development